Sign Up to like & get
recommendations!
1
Published in 2022 at "Molecular carcinogenesis"
DOI: 10.1002/mc.23413
Abstract: In the present study, we performed a comparative stage-specific pathological and molecular marker evaluation of TMPRSS2-ERG fusion and PTEN loss-driven (TMPRSS2-ERG. Ptenflox/flox ) versus non-fusion-driven prostate tumorigenesis (Hi-Myc) in mice. Anterior, ventral, and dorsolateral prostates…
read more here.
Keywords:
fusion driven;
fusion;
erg fusion;
stage ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Nature Reviews Urology"
DOI: 10.1038/nrurol.2017.208
Abstract: more frequently in very-low-risk and low-risk prostate cancer tumours than in tumours in higher risk categories. Furthermore, fusions containing interstitial genes are less likely to be associated with biochemical recurrence. Identifying patients with fusion-positive cancer…
read more here.
Keywords:
risk;
tmprss2 erg;
erg fusion;
low risk ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2020 at "Oncotarget"
DOI: 10.18632/oncotarget.27534
Abstract: Introduction: Oncogenic activation of ERG resulting from TMPRSS2-ERG gene fusion is a key molecular genetic alteration in prostate cancer (CaP). The frequency of ERG fusion is variable by race; however, there are limited data available…
read more here.
Keywords:
status;
prostate;
erg fusion;
fusion status ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14051118
Abstract: Simple Summary In addition to its role in development and in the vascular and hematopoietic systems, ERG plays a central role in prostate cancer. Approximately 40–50% of prostate cancer cases are characterized by ERG gene…
read more here.
Keywords:
erg fusion;
prostate;
prostate cancer;
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Cancer"
DOI: 10.7150/jca.16751
Abstract: Background: Recent discovery of gene rearrangements have brought a new look to the molecular pathogenesis of cancer. Gene fusions occur in nearly 60% of prostate adenocarcinoma, being the TMPRSS2-ERG one of the most common. Evidence…
read more here.
Keywords:
prostate;
erg fusion;
expression;
role ... See more keywords